Challenges in the clinical utility of the serum test for HER2 ECD - Wikidata - wikimedia - TriplyDB

Challenges in the clinical utility of the serum test for HER2 ECD

Challenges in the clinical utility of the serum test for HER2 ECD

http://www.wikidata.org/entity/Q26861754

about

ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer.Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer Monitoring serum HER2 levels in breast cancer patients.Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters.Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer.Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer.Quantification of Circulating Cancer Biomarkers via Sensitive Topographic Measurements on Single Binder Nanoarrays.

P2860

Q33772914-1489DBA0-706D-4125-ADB5-22E3C0095FC7 Q33966430-90785585-D4D4-4B38-B303-746CBF74BBAE Q34967515-8A7EBD61-E449-4F0C-A187-D9F7EAEBE46F Q35686002-BCC8FFF4-6D30-4F33-8C05-6AD56C123DBB Q37109466-B1481DC3-CDCB-4BB7-BAEB-4B9DA567117E Q37341891-E6C844F7-212B-4F9E-BAAF-E08CEE65CA3F Q37367705-D36A93E6-1C45-49CA-9698-39D89DF92360 Q37632854-65B769A1-B97F-45A4-B754-2546A5374DC9 Q37703506-6C524570-B665-4E6E-A5E5-82B994002840 Q49787807-512C4830-70C3-4D00-9958-000C4EDABD1A Q55715013-5542A38B-E57F-4038-BF57-9C68A603D198

P2860

Challenges in the clinical utility of the serum test for HER2 ECD

http://www.wikidata.org/entity/Q26861754

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Challenges in the clinical utility of the serum test for HER2 ECD

@ast

Challenges in the clinical utility of the serum test for HER2 ECD

@en

Challenges in the clinical utility of the serum test for HER2 ECD

@nl

type

label

Challenges in the clinical utility of the serum test for HER2 ECD

@ast

Challenges in the clinical utility of the serum test for HER2 ECD

@en

Challenges in the clinical utility of the serum test for HER2 ECD

@nl

prefLabel

Challenges in the clinical utility of the serum test for HER2 ECD

@ast

Challenges in the clinical utility of the serum test for HER2 ECD

@en

Challenges in the clinical utility of the serum test for HER2 ECD

@nl

P1433

Q26861754-46B0985C-8C03-4086-9F08-B5D2E71BE21B

P1476

Q26861754-0FBA438C-CD57-44AA-9BF0-A208F51EEBF9

P2093

Q26861754-6EAAEE1B-088A-4AA7-BAC7-F9E841F4468C

Q26861754-7768F06F-1A73-4B42-9C33-612E1D88CEBB

Q26861754-9E551FE8-E117-453C-9CD2-49BE30C92760

Q26861754-A9065BE5-A420-491F-9D65-74C36A463893

Q26861754-C0F38F59-018F-4D82-8FE3-337CCB4A5B7F

Q26861754-F0AFCC87-2FF9-44A7-A0F0-686878301334

P2860

Q26861754-010189DE-B69A-48E8-839A-AE8B4CDD68EA

Q26861754-04271DD4-8400-45BF-AF42-2C3977FB0841

Q26861754-0435AAF8-35FE-4833-BAB2-2DE2470FE017

Q26861754-1440BFE8-56C1-4B8D-BF19-DE6228DD8FC5

Q26861754-17C03430-9D13-4CEE-9C9C-5F0593B9DBF3

Q26861754-17EF59CE-1666-44F9-B13A-4E66D082EC73

Q26861754-223D0C1C-BE7C-4350-897E-EFBDB4D97C0D

Q26861754-23F8CA0E-5EEF-4C7A-B005-732D4024ED92

Q26861754-2702229B-F3DE-4E7F-9937-762CE3A9DA48

Q26861754-2D760CB7-1192-4813-ACB0-9C3636E71813

P304

Q26861754-D806DE3B-2DF2-4154-AE94-7D28FA1EC19A

P31

Q26861754-15AD67B2-CFED-4E9C-B0CC-D9D7F49AAA75

P3181

Q26861754-1C78E3E4-D113-41CB-A9DE-83C9BB0D5538

P356

Q26861754-8A4FECD7-7DA3-45F3-8C14-A3F2E1069EA3

P407

Q26861754-FDFA4EF7-B73B-4C8F-965C-72A810853323

P433

Q26861754-884ED692-7EFE-4A6E-BDD3-4723EAC4BB10

P478

Q26861754-9C5E5A6D-F084-4581-B7DA-FF9A2C11FB88

P577

Q26861754-A620571F-F2DE-449B-8FE3-887858816522

P5875

Q26861754-8FECEE8A-FECA-4B93-A31F-974A99791239

P698

Q26861754-3CA1EDB6-6D7E-493C-A174-92A17D4E1DCC

P932

Q26861754-10CC140B-94ED-4304-9DA0-4BD077F5E460

P3181

P356

J.BBCAN.2012.03.012

P1433

Biochimica et Biophysica Acta

P1476

Challenges in the clinical utility of the serum test for HER2 ECD

@en

P2093

Hongtao Zhang

http://www.w3.org/2001/XMLSchema#string

Julia C. Tchou

http://www.w3.org/2001/XMLSchema#string

Lian Lam

http://www.w3.org/2001/XMLSchema#string

Marla Yee

http://www.w3.org/2001/XMLSchema#string

Nicholas McAndrew

http://www.w3.org/2001/XMLSchema#string

Ting Fu

http://www.w3.org/2001/XMLSchema#string

P2860

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancer

Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Inclusion of a non-immunoglobulin binding protein in two-site ELISA for quantification of human serum proteins without interference by heterophilic serum antibodies.

Human anti-animal antibody interferences in immunological assays.

Human anti-mouse antibodies.

P304

199-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3132103

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BBCAN.2012.03.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1826

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224810277

http://www.w3.org/2001/XMLSchema#string

P698

22521738

http://www.w3.org/2001/XMLSchema#string

P932

3362659

http://www.w3.org/2001/XMLSchema#string